DEI CAS, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 114
AS - Asia 46
NA - Nord America 28
AF - Africa 13
OC - Oceania 2
SA - Sud America 1
Totale 204
Nazione #
IT - Italia 41
US - Stati Uniti d'America 25
IE - Irlanda 23
CN - Cina 11
FR - Francia 11
GB - Regno Unito 11
DE - Germania 10
VN - Vietnam 9
CZ - Repubblica Ceca 8
IN - India 8
EG - Egitto 5
KE - Kenya 5
ID - Indonesia 4
IQ - Iraq 4
CA - Canada 3
KR - Corea 3
BY - Bielorussia 2
JO - Giordania 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
ES - Italia 1
KW - Kuwait 1
KZ - Kazakistan 1
NG - Nigeria 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SE - Svezia 1
TW - Taiwan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 204
Città #
Dublin 22
Parma 16
Dong Ket 9
London 7
Nairobi 5
Hangzhou 4
Bologna 3
Bremen 3
Council Bluffs 3
Ashburn 2
Boardman 2
Cochin 2
Mcallen 2
Milan 2
Nanjing 2
Neviano degli Arduini 2
Sant'ilario D'enza 2
Tappahannock 2
Toronto 2
Amherst 1
Bangalore 1
Beijing 1
Bengaluru 1
Cairo 1
Caorso 1
Chennai 1
Duncan 1
Gwalior 1
Innsbruck 1
Jakarta 1
Karachi 1
Kunming 1
Leeds 1
Los Angeles 1
Madrid 1
Malmö 1
Manchester 1
Marlborough 1
Medellín 1
Medolla 1
Mestre 1
Miami 1
Narbonne 1
Nashville 1
Neustadt 1
Paderborn 1
Port Saint Lucie 1
Pune 1
Raritan 1
Segrate 1
Shanghai 1
Sydney 1
Teramo 1
Tizi 1
Trieste 1
Verona 1
Wellington 1
Würzburg 1
Zhengzhou 1
Totale 132
Nome #
Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes, file e177fbc4-1323-50b0-e053-d805fe0adaee 32
Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes, file e177fbc4-1325-50b0-e053-d805fe0adaee 30
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations, file e177fbc7-144a-50b0-e053-d805fe0adaee 27
Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach., file e177fbc4-3b29-50b0-e053-d805fe0adaee 21
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management, file e177fbc7-71e4-50b0-e053-d805fe0adaee 16
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation?, file e177fbc4-9e77-50b0-e053-d805fe0adaee 13
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study, file 976d2b27-ba56-4365-9544-2af05a216a96 11
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study, file daaab19d-dcf7-49da-bced-e6132f9d1e48 11
Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds, file e177fbc7-a892-50b0-e053-d805fe0adaee 8
A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause-effect relationship between hypoglycaemia and the risk of in-hospital mortality, file e177fbc7-a5eb-50b0-e053-d805fe0adaee 5
Continuous subcutaneous insulin infusion in Italy: third national survey, file a31c69e8-cddb-41de-ba61-0895b1aa2326 4
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006, file e177fbc5-de29-50b0-e053-d805fe0adaee 4
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project, file e177fbc7-a7b9-50b0-e053-d805fe0adaee 4
Prevention and management of chronic heart failure in patients at risk, file e177fbc4-1321-50b0-e053-d805fe0adaee 3
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health, file 1b4f0508-be66-406f-b4bc-09cd1fbdc3b0 2
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: A 12-month randomized controlled trial in patients with type 2 diabetes, file e177fbc5-67b3-50b0-e053-d805fe0adaee 2
Performance and antrhropometric characteristics of Elite Rugby Players., file e177fbc5-d8b3-50b0-e053-d805fe0adaee 2
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006, file e177fbc5-e853-50b0-e053-d805fe0adaee 2
Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men, file e177fbc4-2582-50b0-e053-d805fe0adaee 1
Effects of the GABAergic agonist baclofen on endurance performance in recreational athletes: a pilot study, file e177fbc4-2f88-50b0-e053-d805fe0adaee 1
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health, file e177fbc5-dd54-50b0-e053-d805fe0adaee 1
Metabolomic Changes after Coffee Consumption: New Paths on the Block, file e177fbc6-f972-50b0-e053-d805fe0adaee 1
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health., file e177fbc7-3e11-50b0-e053-d805fe0adaee 1
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function, file e177fbc7-42fe-50b0-e053-d805fe0adaee 1
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events, file e177fbc7-a218-50b0-e053-d805fe0adaee 1
Totale 204
Categoria #
all - tutte 553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 2 0 0 10
2021/202219 1 1 4 0 0 2 6 0 0 3 0 2
2022/202364 0 0 1 4 11 6 7 4 25 2 4 0
2023/202415 1 0 0 0 1 2 5 3 2 1 0 0
Totale 204